SCHEDULE 13G FOR SYNDAX PHARMACEUTICALS, INC. BY DOMAIN PARTNERS VIII, L.P.

Company

Syndax Pharmaceuticals Inc

Filed

January 9, 2017

Accession Number

0000904454-17-000013

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →